CAS: 32768-20-0 - Methylsalicylicacidsodiumsalt; 97%
Formula:C8H7NaO3
InChI:InChI=1S/C8H8O3.Na/c1-5-3-2-4-6(7(5)9)8(10)11;/h2-4,9H,1H3,(H,10,11);
InChI key:InChIKey=DQQIDWMXSMXDOY-UHFFFAOYSA-N
SMILES:[Na].O=C(O)C1=CC=CC(=C1O)C
- Synonyms:
- 2,3-Cresotic acid, monosodium salt
- 3-Methylsalicylic acid sodium salt
- Benzoic acid, 2-hydroxy-3-methyl-, monosodium salt
- Benzoic acid, 2-hydroxy-3-methyl-, sodium salt (1:1)
- Sodium 2-Hydroxy-3-Methylbenzoate
- Sodium 3-methylsalicylate
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Sodium 3-Methylsalicylate REF: 3B-C0411CAS: 32768-20-0 | >97.0%(T)(HPLC) | 101.00 € | Tue 03 Dec 24 | |
Sodium 2-hydroxy-3-methylbenzoate REF: IN-DA003JRYCAS: 32768-20-0 | 98% | 26.00 €~201.00 € | Tue 10 Dec 24 | |
Sodium 2-carboxy-6-methylphenolate REF: 10-F724863CAS: 32768-20-0 | 98% | 82.00 €~257.00 € | Wed 11 Dec 24 | |
Sodium 3-Methylsalicylate REF: 3D-HBA76820CAS: 32768-20-0 | Min. 95% | - - - | Discontinued product |
Sodium 3-Methylsalicylate
CAS:32768-20-0
Formula:
C8H7NaO3
Purity:
>97.0%(T)(HPLC)
Color and Shape:
White to Light yellow to Light red powder to crystal
Molecular weight:
174.13
Ref: 3B-C0411
25g | 101.00 € |
Estimated delivery in United States, on Tuesday 3 Dec 2024
Sodium 2-hydroxy-3-methylbenzoate
CAS:32768-20-0
Formula:
C8H7NaO3
Purity:
98%
Color and Shape:
Solid
Molecular weight:
174.1292
Ref: IN-DA003JRY
1g | 26.00 € | ||
5g | 35.00 € | ||
25g | 89.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Ref: 10-F724863
25g | 82.00 € | ||
100g | 257.00 € |
Estimated delivery in United States, on Wednesday 11 Dec 2024
Sodium 3-Methylsalicylate
CAS:32768-20-0
Sodium 3-Methylsalicylate is a form of salicylic acid, which is a type of phenolic acid. …
Formula:
C8H7NaO3
Purity:
Min. 95%
Molecular weight:
174.13 g/mol
Ref: 3D-HBA76820
10g | Discontinued | Request information | |
25g | Discontinued | Request information | |
50g | Discontinued | Request information | |
100g | Discontinued | Request information | |
250g | Discontinued | Request information |